Related Experiment Video
Updated: May 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile dysfunction in men treated for testicular cancer
Raanan Tal1, Doron S Stember, Nina Logmanieh
1Male Sexual and Reproductive Medicine Program, Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Erectile dysfunction (ED) in men after testicular cancer (TC) treatment shows normal erectile hemodynamics, suggesting an adrenaline-mediated cause. While most survivors respond to PDE5 inhibitors, a notable portion do not.
Area of Science:
- Urology
- Oncology
- Sexual Medicine
Background:
- Testicular cancer (TC) treatment can lead to erectile dysfunction (ED).
- Understanding the specific characteristics of ED in TC survivors is crucial for effective management.
Purpose of the Study:
- To investigate the unique features of erectile dysfunction (ED) in men following testicular cancer (TC) diagnosis and treatment.
- To characterize the hemodynamic profile and treatment response in TC survivors with ED.
Main Methods:
- A cohort of 76 men treated for TC underwent a comprehensive sexual function evaluation.
- Methods included International Index of Erectile Function (IIEF) questionnaire, hormone level assessment, and penile duplex Doppler ultrasonography (DUS).
Main Results:
- Patients were young (mean age 29 years) with a low incidence of vascular risk factors.
- All patients exhibited normal erectile hemodynamics on DUS, despite varying TC treatments (chemotherapy, radiation, RPLND).
- 88% of patients responded to phosphodiesterase type 5 inhibitors (PDE5i), while 12% did not.
Conclusions:
- ED in TC survivors appears to be primarily mediated by non-vascular factors, potentially adrenaline-related.
- While PDE5 inhibitors are effective for most, a subset of TC survivors with ED requires further investigation and alternative treatment strategies.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Infertility in Males
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Spermatogenesis
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
